During Pneumocystis pneumonia (PcP), the number of alveolar macrophages (AMs) falls, impairing the innate immune system. This defect is mainly due to increased rate of apoptosis caused by elevated levels of intracellular polyamines. Preliminary results indicate that the levels of ornithine decarboxylase, antizyme inhibitor, and polyamine oxidase that are involved in polyamine synthesis and catabolism are increased during the infection. Increased expression of antizyme inhibitor (AZI) leads to increased polyamine production and uptake, thus raising intracellular polyamine and reactive oxygen species (ROS) levels. ROS damage the mitochondria of AMs, resulting in apoptosis. The central hypothesis of this project is that preventing the increase in intracellular polyamine levels will improve the vitality of AMs, leading to a more effective organism clearance. The long-term goal of this project is to understand the mechanism of pathogenesis of PcP and to develop methods to prevent AMs from undergoing apoptosis, thus enhancing the ability of the host to defend against the infection. To achieve this goal, the mechanism by which Pneumocystis (Pc) induces AZI over-expression will be determined. Preliminary data suggest that Pc cell wall components stimulate AMs to increase AZI expression. Further investigations will be performed to characterize the role of Pc 2-glucan, the major component of the Pc cell wall, in the induction of AZI over-expression. The possibility that other Pc components, such as major surface glycoprotein or mannan, are involved in Pc-induced AZI over-expression will also be examined, and macrophage receptors that transmit the signal to AMs leading to AZI over-expression will be identified.

Public Health Relevance

Pneumocystis, the most common opportunistic pathogen in AIDS patients, induces alveolar macrophage apoptosis in order to increase its chance of survival and reproduction in immunocompromised hosts. This is achieved by increasing the production and uptake of polyamines thus raising polyamine levels in alveolar macrophages. The proposed research will investigate the mechanisms by which Pneumocystis increases polyamine levels in alveolar macrophages.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Small Research Grants (R03)
Project #
Application #
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Duncan, Rory A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Lei, Guang-Sheng; Zhang, Chen; Lee, Chao-Hung (2015) Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia. Infect Immun 83:572-82
Lei, Guang-Sheng; Zhang, Chen; Zimmerman, Michelle K et al. (2015) Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. Antimicrob Agents Chemother 60:1289-97
Lei, Guang-Sheng; Zhang, Chen; Shao, Shoujin et al. (2013) All-trans retinoic acid in combination with primaquine clears pneumocystis infection. PLoS One 8:e53479
Zhang, Chen; Lei, Guang-Sheng; Shao, Shoujin et al. (2012) Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infect Immun 80:3634-41